Abstract
To evaluate the effectiveness of modified microvascular decompression in classic trigeminal neuralgia.
The study included 16 patients with classic trigeminal neuralgia resistant to long-term carbamazepine therapy. The diagnosis was confirmed by clinical and neurological examination and MRI with 3D-TOF and FIESTA protocols. All patients underwent modified microvascular decompression via retrosigmoid access with vessel dislocation and combined isolation of the trigeminal nerve root (Teflon, Takahomb, adipose tissue).
Complete regression of pain syndrome immediately after surgery was achieved in all 16 patients. The median BNI-PS score decreased from 4 [4-5] to 1 [1-1], and the median VAS score decreased from 7 [7-8] to 2 [2-2]; both differences were statistically significant (exact Wilcoxon signed-rank test, p<0.001). No disease recurrence was observed during the mean follow-up period of 1 year and 5 months.
Modified microvascular decompression with vessel dislocation and combined isolation of the trigeminal nerve root was associated with a statistically significant decrease in pain intensity and no registered recurrence during follow-up. Considering the small sample size, these results should be interpreted as preliminary evidence of the clinical effectiveness of the technique and require further confirmation in larger comparative studies.
Keywords
Full Text
Download Article as PDF
Full article in PDF format
References
- Lazarchuk D.M., Alekseev G.N., Kamadey O.O., Chemidronov S.N. Microvascular decompression in the treatment of patients with trigeminal neuralgia. Aspirantskiy vestnik Povolzhya. 2019;1-2:101-106 DOI: 10.17816/2072-2354.2019.19.1.101-106
- Ruiz-Juretschke F, González-Quarante LH, García-Leal R, Martínez de Vega V. Neurovascular relations of the trigeminal nerve in asymptomatic individuals studied with high-resolution threedimensional magnetic resonance imaging. Anat Rec (Hoboken). 2019; 302(4): 639-645 [https://doi.org/10.1002/ar.23818](https://doi.org/10.1002/ar.23818)
- Crespi J., Bratbak D., Dodick D.W., et al. Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia. Headache. 2019;59(8):1229-1239. DOI: 10.1111/head.13608
- Wang W, Yu F, Kwok SC, Wang Y, Yin J. Microvascular Decompression for Trigeminal Neuralgia Caused by Venous Offending on the Ventral Side of the Root Entrance/Exit Zone: Classification and Management Strategy. Frontiers in Neurology. 2022;13:864061. DOI: 10.3389/fneur.2022.864061
- Amaya Pascasio L., De La Casa-Fages B., Esteban de Antonio E., et al. Microvascular decompression for trigeminal neuralgia: A retrospective analysis of long-term outcomes and prognostic factors. Neurologia (Engl Ed). 2023;38(9):625-634. DOI: 10.1016/j.nrleng.2021.03.010
- Wang J.J., Zhao Z., Chai S.S., et al. Microvascular decompression as a second step treatment for trigeminal neuralgia in patients with failed two-isocentre gamma knife radiosurgery. Neurosurgical Review. 2022;45(1):783-791. DOI: 10.1007/s10143-021-01587-1
- Yang L., Cheng H. Surgical technique management of microvascular decompression for trigeminal neuralgia. Clinical Neuroscience. 2022;75(11-12):369-375. DOI: 10.18071/isz.75.0369
- Khaleghi M., Carlstrom L.P., Weber M.D., et al. Microvascular Decompression for Trigeminal Neuralgia Caused by Vascular Compression on the Trigeminal Sensory Nucleus and Descending Trigeminal Tract. World Neurosurgary. 2024;183:106-112. DOI: 10.1016/j.wneu.2023.12.087
- Jiang H., Zou D., Wang P., et al. Case report: Fully endoscopic microvascular decompression for trigeminal neuralgia. Frontiers in Neurology. 2023;13:1090478. DOI: 10.3389/fneur.2022.1090478
- Mun Seng Chong. Guidelines for the management of trigeminal neuralgia. Cleveland Clinic Journal of Medicine. 2023; 90 (6):355-362; DOI: 10.3949/ccjm.90a.22052